49 results on '"Omazic B"'
Search Results
2. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT
3. ALLOGENEIC STEM CELL TRANSPLANTATION IN PANCREATIC CARCINOMA: WP-O029
4. LONG-TERM FOLLOW UP OF PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION AS TREATMENT FOR SOLID TUMORS: PH-O122
5. A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation
6. Risk factors for acute graft-versus-host disease grades II–IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors—a single centre study
7. Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases
8. A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation
9. Altered expression of receptors for thyroid hormone and insulin-like growth factor-1 during reconstitution after allogeneic hematopoietic stem cell transplantation
10. Is there a graft-versus-MDS effect after haematopoietic allogeneic stem cell transplantation?: P1167
11. Improved survival after allogeneic haematopoietic stem cell transplantation in recent years: P646
12. Graft failure in the modern era of allogeneic haematopoietic stem cell transplantation: P647
13. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study
14. T-Cell Receptor Vβ Repertoire after Myeloablative and Reduced Intensity Conditioning Allogeneic Haematopoietic Stem Cell Transplantation
15. Reconstitution of the Ig Heavy Chain CDR3 Repertoire after Allogeneic Haematopoietic Stem Cell Transplantation with Myeloablative or Reduced-Intensity Conditioning Regimens
16. Memory B lymphocytes determine repertoire oligoclonality early after haematopoietic stem cell transplantation
17. Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation
18. Functionality testing of stem cell grafts to predict infectious complications after allogeneic hematopoietic stem cell transplantation
19. A Prospective Randomized Study Comparing Reduced-Intensity Conditioning and Myeloablative Conditioning in Patients with Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
20. Ten Years Experience of Home-Care During the Neutropenic Phase After Allogeneic Hematopoietic Stem Cell Transplantation
21. Risk factors for acute graft-versus-host disease grades II–IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors—a single centre study
22. Cervical fetal fibronectin correlates to prostaglandin E2-induced cervical ripening and can be identified in cervical tissue.
23. Mesenchymal stem cells for treatment of severe acute graft-versus-host disease
24. Classification of Croatian winegrowing regions based on bioclimatic indices
25. TCR+CD4-CD8- T cells in antigen-specific MHC class I-restricted T-cell responses after allogeneic hematopoietic stem cell transplantation
26. Mass Cytometry and Topological Data Analysis Reveal Immune Parameters Associated with Complications after Allogeneic Stem Cell Transplantation.
27. A Preliminary Report: Radical Surgery and Stem Cell Transplantation for the Treatment of Patients With Pancreatic Cancer.
28. A phase I dose escalation trial of AXP107-11, a novel multi-component crystalline form of genistein, in combination with gemcitabine in chemotherapy-naive patients with unresectable pancreatic cancer.
29. Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer.
30. HLA, GVHD, and parenteral nutrition are risk factors for hepatic complications in pediatric HSCT.
31. Photochemotherapy of Cutaneous Graft-versus-Host Disease May Reduce Concomitant Visceral Disease.
32. Hypogammaglobulinemia in children after allogeneic hematopoietic stem cell transplantation: a cytokine mediated immunoglobulin isotype class switch arrest?
33. Vitamin d levels affect outcome in pediatric hematopoietic stem cell transplantation.
34. TCR+CD4-CD8- T cells in antigen-specific MHC class I-restricted T-cell responses after allogeneic hematopoietic stem cell transplantation.
35. Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults.
36. Many days at home during neutropenia after allogeneic hematopoietic stem cell transplantation correlates with low incidence of acute graft-versus-host disease.
37. Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study.
38. WITHDRAWN: Treatment with mesenchymal stromal cells does not improve long-term survival in patients with severe acute GVHD.
39. Granulocyte colony-stimulating factor induced acute and chronic graft-versus-host disease.
40. GVHD prophylaxis using low-dose cyclosporine improves survival in leukaemic recipients of HLA-identical sibling transplants.
41. The allogeneic graft-versus-cancer effect.
42. Immune reconstitution after HLA mismatched haemopoietic stem-cell transplantation.
43. Reduced-intensity allogeneic hematopoietic stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European group for blood and marrow transplantation experience.
44. Hemorrhagic cystitis: a retrospective single-center survey.
45. Insulin-like growth factor-1 receptor RNA expression in hematopoietic stem cell transplanted patients does not correlate with graft-versus-host disease.
46. Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.
47. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
48. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.
49. Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.